Casirivimab
Product Specifications
CAS Number
2415933-42-3
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Casirivimab (REGN10933), a human monoclonal antibody targeting the SARS-CoV-2 virus responsible for COVID-19, demonstrates reduced efficacy against emerging variants. When combined with Imdevimab, it significantly lowers viral load and enhances disease outcomes [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416316521447430/T76846
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1150366-01 0.02 mg (E-Coli)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details 
MBS1150366-02 0.02 mg (Yeast)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details MBS1150366-03 0.1 mg (E-Coli)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details 
MBS1150366-04 0.1 mg (Yeast)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details MBS1150366-05 0.02 mg (Baculovirus)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details MBS1150366-06 0.02 mg (Mammalian-Cell)
Recombinant Enterobacter sp. DNA replication terminus site-binding protein (tus)
Ask
View Details